FDA Latest Advances in the Approvals of Biosimilars
Sign up to be notified of new teleseminars daily! |
| Description: | FDA Latest Advances in the Approvals of Biosimilars Friday, 28th April, 2017 | 04:00 PM IST| 11:30 AM BST REGISTER NOW! The presentation will cover the following areas: The submissions of biosimilars to the FDA which have taken place of US biosimilars that have not been submitted in the EU FDA tackling monoclonal antibodies under abbreviated BLA’s FDA approval of peglyated filgrastim leading to withdrawal of the ABLA FDA publish long awaited interchangeability guidance in February 2017, with huge implications. Various FDA guidances colelctively the recent clinical pharmacology one and interchangeability EMA clinical basis of approval of 2016 biosimilars and the current most eminent pipeline The current first ABLA reviews |
| URL: | http://www.biopractice.com/webinar/live/145 |
| Date: | Friday, May 5, 2017 |
| Time: | 4:00pm-5:00pm UTC |
| Duration: | 1 hour |
| Access: | Public |
| Created by: | Public Access |
| Updated: | Monday, May 1, 2017 7:34am UTC |
| : | €249 |
| : | 6462168860 |
| : | marketing.biopractice@gmail.com |
| : | Sachin |
| : | 6462168860 |
| Comments: | None |